Effects of i.v. push administration on β-lactam pharmacodynamics
Author:
Affiliation:
1. Parallon Supply Chain Solutions, Richmond, VA
Publisher
Oxford University Press (OUP)
Subject
Health Policy,Pharmacology
Link
http://academic.oup.com/ajhp/article-pdf/74/9/e170/28450552/ajhpe170.pdf
Reference30 articles.
1. Institute for Safe Medication Practices. ISMP safe practice guidelines for adult IV push medications. A compilation of safe practices from the ISMP adult I.V. Push Medication Safety Summit (2015). www.ismp.org/Tools/guidelines/ivsummitpush/ivpushmedguidelines.pdf (accessed 2016 Jan 22).
2. Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective;Mouton;Drug Resist Updat,2011
3. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men;Craig;Clin Infect Dis,1998
4. DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients?;Roberts;Clin Infect Dis,2014
5. Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis;Falagas;Clin Infect Dis,2013
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Intravenous push antibiotics in the emergency department: Education and implementation;American Journal of Health-System Pharmacy;2024-02-19
2. Antibiotics Administered via Intravenous Push Versus Intravenous Piggyback to Adult Patients in the Emergency Department: a Randomized Trial;SN Comprehensive Clinical Medicine;2023-07-17
3. Outcomes of Intravenous Push versus Intermittent Infusion Administration of Cefepime in Critically Ill Patients;Antibiotics;2023-06-01
4. Beta-Lactam Probability of Target Attainment Success: Cefepime as a Case Study;Antibiotics;2023-02-23
5. Pushing the agenda for intravenous push administration in outpatient parenteral antimicrobial therapy;Therapeutic Advances in Infectious Disease;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3